Should combination therapy be the paradigm for future nonalcoholic steatohepatitis clinical trials?
about
Should combination therapy be the paradigm for future nonalcoholic steatohepatitis clinical trials?
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Should combination therapy be ...... eatohepatitis clinical trials?
@en
Should combination therapy be ...... eatohepatitis clinical trials?
@nl
type
label
Should combination therapy be ...... eatohepatitis clinical trials?
@en
Should combination therapy be ...... eatohepatitis clinical trials?
@nl
prefLabel
Should combination therapy be ...... eatohepatitis clinical trials?
@en
Should combination therapy be ...... eatohepatitis clinical trials?
@nl
P2860
P356
P1433
P1476
Should combination therapy be ...... eatohepatitis clinical trials?
@en
P2093
Kathleen E Corey
Naga Chalasani
P2860
P304
P356
10.1002/HEP.24696
P407
P577
2011-11-01T00:00:00Z